Future Directions for the National Healthcare Quality and Disparities Reports

Table F-1: EPV-QIR Calculations for 18 NHQR Measures

Table F-1. EPV-QIR Calculations for 18 NHQR Measures

Mnemonic NHQR Measure Denominator Population Pop. VPI (QALYs) Pop. VCI (QALYs) Pop. Max VQI (QALYs)
NHQR_DMHTN Percent of adults with diagnosed diabetes with most recent blood pressure <140/80 mm/Hg 17,268,973 7,021,537 4,107,599 2,913,938
NHQR_DMCHOL Adults age 40 and over with diagnosed diabetes with total cholesterol <200 mg/dL 17,268,973 1,828,056 1,003,602 1,003,602 824,453
NHQR_DMFOOT Adults age 40+ with diagnosed diabetes who had their feet checked for sores or irritation in the calendar year 17,268,973 2,326,165 1,644,599 681,566
NHQR_DMHBA1C Percent of adults with diagnosed diabetes with HbA1c level >9.5% (poor control); <7.0 (optimal); <9.0 (minimally acceptable) 17,268,973 1,474,394 805,019 669,375
NHQR_HIVEVER People ages 15-44 who ever received an HIV test outside of blood donation 126,006,034 529,704 241,545 288,159
NHQR_PAP3YR Percent of women (age 18 and over) who report they had a Pap smear within the past 3 yrs 15,272,448 2,120,558 1,903,757 216,801
NHQR_DMEYE Adults age 40+ with diagnosed diabetes who received a dilated eye examination in the calendar year 17,268,973 414,132 247,237 166,895
NHQR_CRC50EVERCOLON Adults age 50 and over who ever received a colonoscopy, sigmoidoscopy, or proctoscopy 14,992,188 366,829 219,454 147,375
NHQR_BRCA2YRMAMM Percent of women (age 40+) who report they had a mammogram within the past 2 year 60,428,554 1,167,474 1,046,640 120,833
NHQR_CRCBIFOBT Adults age 50 and over who received a fecal occult blood test (FOBT) in the last 2 years 6,895,908 253,938 152,497 101,441
NHQR_CAPVACC65EVER Percent of individuals age 65+ who ever received a pneumococcal vaccination 38,869,716 161,291 92,420 68,871
NHQR_BSICVC
VQI represents QALYs that can be saved by using chlorhexidine silver sulfadiazine coated catheters (external coat)
Bloodstream infections (BSIs) per 1,000 central venous catheter (CVC) placements 140,000 0 -27,809 27,809
NHQR_BSICVC
VQI represents QALYs that can be saved by using silver, platinum and carbon coated catheters
Bloodstream infections (BSIs) per 1,000 central venous catheter (CVC) placements 140,000 0 -27,095 27,095
NHQR_BSICVC
VQI represents QALYs that can be saved by using chlorhexidine minocycline and rifampicin coated catheters
Bloodstream infections (BSIs) per 1,000 central venous catheter (CVC) placements 140,000 0 -24,864 24,864
NHQR_BSICVC
VQI represents QALYs that can be saved by using chlorhexidine silver sulfadiazine coated catheters (internal + external coat)
Bloodstream infections (BSIs) per 1,000 central venous catheter (CVC) placements 140,000 0 -23,001 23,001
NHQR_AMIBB Percent of AMI patients administered beta blockers prescribed at discharge 682,699 123,172 109,623 13,549
NHQR_HFACE Percent of hospital patients with heart failure and left ventricular systolic dysfunction who were prescribed ACE inhibitor or ARB at discharge 295,101 64,976 55,359 9,616
NHQR_AMIACE Percent of AMI patients with LVSD prescribed ACE inhibitor at discharge 185,695 44,830 38,509 6,321

Return to Document

 

Page last reviewed October 2014
Internet Citation: Table F-1: EPV-QIR Calculations for 18 NHQR Measures. October 2014. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/final-reports/iomqrdrreport/futureqrdrapftab1.html